Novavax, Inc.
(NASDAQ : NVAX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -1.36%348.780.0%$6636.54m
BNTXBioNTech SE 3.72%340.560.0%$1133.65m
SNSSSunesis Pharmaceuticals, Inc. 4.28%10.970.7%$766.84m
NVAXNovavax, Inc. 3.28%185.2279.8%$670.36m
AMGNAmgen, Inc. -0.53%240.271.3%$496.62m
BIIBBiogen, Inc. 2.04%333.391.7%$440.05m
VRTXVertex Pharmaceuticals, Inc. -1.16%199.251.9%$409.94m
GILDGilead Sciences, Inc. 0.21%68.431.0%$402.12m
REGNRegeneron Pharmaceuticals, Inc. 0.60%578.062.7%$356.01m
ILMNIllumina, Inc. -0.40%493.793.5%$262.97m
NTLAIntellia Therapeutics, Inc. -2.24%138.682.3%$258.00m
CRSPCRISPR Therapeutics AG 1.82%123.220.6%$147.36m
EXASEXACT Sciences Corp. 1.37%109.3218.1%$125.28m
SGENSeagen Inc. 0.25%153.775.8%$120.52m
XBIOXenetic Biosciences, Inc. 17.44%4.780.0%$120.00m

Company Profile

Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.